Anúncio
Anúncio

CLPT

CLPT logo

ClearPoint Neuro, Inc. Common Stock

14.94
USD
Patrocinado
-0.38
-2.45%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

15.13

+0.20
+1.31%

Relatórios de Lucros CLPT

Rácio de surpresa positiva

CLPT separação 15 de 26 últimas estimativas.

58%

Próximo Relatório

Data do Próximo Relatório
24 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$10.25M
/
-$0.20
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+15.69%
/
-4.76%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+31.91%
/
--

ClearPoint Neuro, Inc. Common Stock earnings per share and revenue

On 06 de nov. de 2025, CLPT reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.20 USD, resulting in a -2.94% surprise. Revenue reached 8.86 milhão, compared to an expected 9.79 milhão, with a -9.51% difference. The market reacted with a -13.27% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.20 USD, with revenue projected to reach 10.25 milhão USD, implying an diminuir of -4.76% EPS, and aumentar of 15.69% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
For Q3 2025, ClearPoint Neuro, Inc. Common Stock reported EPS of -$0.21, missing estimates by -2.94%, and revenue of $8.86M, -9.51% below expectations.
The stock price moved down -13.27%, changed from $18.23 before the earnings release to $15.81 the day after.
The next earning report is scheduled for 24 de fev. de 2026.
Based on 4 analistas, ClearPoint Neuro, Inc. Common Stock is expected to report EPS of -$0.20 and revenue of $10.25M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio